Online citations, reference lists, and bibliographies.
← Back to Search

Approach To The Patient With HIV And Coinfecting Tropical Infectious Diseases

C. Karp, R. Colebunders
Published 2006 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1128/CMR.12.4.554
New Insights into Human Cryptosporidiosis
D. P. Clark (1999)
10.1016/S0091-6749(99)70146-6
Eosinophil involvement and serum IgE level in HIV-1-infected children.
J. Onorato (1999)
10.1097/00002030-199706000-00007
The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV‐1 infection: 1‐year follow‐up
N. Bodsworth (1997)
10.1086/515192
Consecutive epidemics of Q fever in a residential facility for drug abusers: impact on persons with human immunodeficiency virus infection.
A. Boschini (1999)
10.1086/314491
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
M. Sulkowski (1998)
10.3201/eid1004.030303
Maternal Malaria and Perinatal HIV Transmission, Western Kenya1,2
J. Ayisi (2004)
Emergence of sporotrichosis in Manipur.
K. R. Devi (2006)
10.1097/00002030-199105000-00020
Syphilis treatment response in HIV-infected individuals.
E. Telzak (1991)
10.1016/S0140-6736(98)03201-2
Changing patterns of mortality across Europe in patients infected with HIV-1
A. Mocroft (1998)
10.1056/NEJMOA021556
Oral miltefosine for Indian visceral leishmaniasis.
S. Sundar (2002)
10.1016/S0140-6736(96)91618-9
Lethal infection by a previously unrecognised metazoan parasite
M. Santamaría-Fríes (1996)
10.7883/YOKEN1952.45.247
A preliminary survey for human immunodeficient virus (HIV) infections in tuberculosis and melioidosis patients in Ubon Ratchathani, Thailand.
Kazuo Kanai (1992)
10.1016/S0002-9343(99)80113-2
Asymptomatic neurocysticercosis in a patient with AIDS and cryptococcal meningitis.
A. White (1995)
10.1001/ARCHPEDI.1992.02160170030011
Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda.
P. Lepage (1992)
[Pneumocystis carinii pneumonia in patients with AIDS in the Congo].
J. M'boussa (1991)
10.1086/375357
Lethal invasive cestodiasis in immunosuppressed patients.
P. D. Olson (2003)
10.1086/338154
A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
S. Chariyalertsak (2002)
10.1002/14651858.CD003108
Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
K. Grimwade (2003)
Higher risk of antimalarial treatment in HIV positive than HIV negative individuals with clinical malaria
JP van Geertruyden (2004)
Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in HIV-infected children in Kinshasa
F T Cutts (1993)
10.1086/381554
Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis.
D. Goletti (2004)
10.1164/AJRCCM.149.6.8004318
Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology.
J. Batungwanayo (1994)
Outcome of hepatitis B virus infection in homosexual men and its relationship to prior HIV infection
S C Hadler (1991)
10.1016/0020-7292(95)80028-b
Mother‐to‐infant transmission of hepatitis C virus
M. Chang (1996)
10.1086/513750
Antibody response to Haemophilus influenzae type b vaccine in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.
F. Kroon (1997)
10.1093/CLINIDS/14.1.127
Acute and chronic Q fever in patients with cancer.
D. Raoult (1992)
10.1097/00002030-200208160-00027
Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.
R. C. Johnson (2002)
JJ: Drug interactions of HIV protease inhibitors
L I Malaty (1999)
10.1016/S0140-6736(84)90241-1
ACQUIRED IMMUNODEFICIENCY SYNDROME IN A HETEROSEXUAL POPULATION IN ZAIRE
P. Piot (1984)
Increased risk of early measles in infants of HIV type 1-seropositive mothers
J E Embree (1992)
10.1086/339444
Remission of cutaneous Mycobacterium haemophilum infection as a result of antiretroviral therapy in a Human Immunodeficiency Virus--infected patient.
V. Paech (2002)
10.1093/infdis/155.1.130
Acanthamoeba meningoencephalitis in a patient with AIDS.
C. Wiley (1987)
10.1046/j.1365-3156.2001.00710.x
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis
J. Blum (2001)
Intestinal parasitic infections in HIV/AIDS and HIV seronegative individuals in a teaching hospital, Ethiopia.
G. Hailemariam (2004)
10.1016/0962-8479(92)90033-G
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.
J. Narain (1992)
10.1089/APC.2005.19.621
Successful treatment of Acanthamoeba rhinosinusitis in a patient with AIDS.
J. Nachega (2005)
10.1086/422396
Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection.
S. Joseph (2004)
10.4269/AJTMH.2007.77.825
Seroprevalence of Entamoeba histolytica infection in HIV-infected patients in China.
Y. Chen (2007)
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
Prevots Dr (2000)
10.1001/JAMA.288.2.199
Hepatitis C and progression of HIV disease.
M. Sulkowski (2002)
10.1001/ARCHNEUR.1993.00540030009006
Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus.
D. Katz (1993)
10.4269/AJTMH.1998.59.784
Reactivation of Chagas' disease in a human immunodeficiency virus-infected patient leading to severe heart disease with a late positive direct microscopic examination of the blood.
A. Sartori (1998)
10.4269/AJTMH.2005.73.1165
Short report: disease severity and outcome of melioidosis in HIV coinfected individuals.
W. Chierakul (2005)
10.1093/CLINIDS/13.3.480
The growing problem of mycoses in patients infected with the human immunodeficiency virus.
R. Diamond (1991)
10.1016/S0002-9343(89)80158-5
Lyme disease concurrent with human immunodeficiency virus infection.
J. C. García-Moncó (1989)
10.1007/S11908-001-0059-7
Preparation of the HIV-infected traveler to the tropics
C. Karp (2001)
False HIV positivity in leprosy (abstract)
M Nuti (1989)
10.1111/j.1439-0507.1987.tb03829.x
Disseminated African Histoplasmosis in a White Heterosexual Male Patient with the Acquired Immune Deficiency Syndrome/Disseminierte Afrikanische Histoplasmose bei einem weißen Heterosexuellen mit AIDS
P. Peeters (1987)
10.1056/NEJM199601043340104
Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee.
N. Vakil (1996)
10.1097/00126334-200306010-00011
Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion.
J. Del Amo (2003)
10.1378/CHEST.100.3.716
Mycobacterium gordonae: a possible opportunistic respiratory tract pathogen in patients with advanced human immunodeficiency virus, type 1 infection.
T. W. Barber (1991)
10.1097/00006454-199602000-00032
Treatment of scabies with ivermectin.
A. Offidani (1999)
10.1086/515171
Editorial Response: Influenza, Influenza Virus Vaccine, and Human Immunodeficiency Virus Infection
R. B. Couch (1999)
Rate of subclinical hepatitis A virus infection in adult HIV-1-infected patients.
S. Ida (2001)
GB: Acanthamoeba meningoencephalitis: Diagnosis by squash preparation of brain biopsy specimen
EK Miyamato (1985)
Hepatitis C in the HIV Atlanta VA Cohort Study: The effect of co-infection on survival
C T Staples (1999)
Successful treatment of disseminated measles in a patient with AIDS: Consideration of antiviral and passive immunotherapy (letter)
L A Ross (1990)
10.1128/IAI.71.11.6668-6671.2003
Increased Density of Human Immunodeficiency Virus Type 1 Coreceptors CCR5 and CXCR4 on the Surfaces of CD4+ T Cells and Monocytes of Patients with Schistosoma mansoni Infection
W. Secor (2003)
10.4269/AJTMH.1992.46.161
A case of human ehrlichiosis acquired in Mali: clinical and laboratory findings.
I. Uhaa (1992)
10.1097/00000372-199304000-00008
Cutaneous acanthamoeba infection associated with leukocytoclastic vasculitis in an AIDS patient.
J. Helton (1993)
10.1128/CMR.6.3.266
The Mycobacterium avium complex.
C. Inderlied (1993)
10.1111/j.1365-4362.1996.tb03008.x
UNUSUAL ASSOCIATION OF AMERICAN CUTANEOUS LEISHMANIASIS AND ACQUIRED IMMUNODEEICIENCY SYNDROME
MARIA CHRISTINA MARQUES NOGUEIRA‐CASTAÑON (1996)
10.1097/00005792-199409000-00004
Systemic Strongyloidiasis in Patients Infected with the Human Immunodeficiency Virus: A Report of 3 Cases and Review of the Literature
J. Celedón (1994)
10.1093/INFDIS/168.4.1045
A prospective evaluation of Mycobacterium avium complex colonization of the respiratory and gastrointestinal tracts of persons with human immunodeficiency virus infection.
J. A. Havlik (1993)
10.2165/00002018-199920020-00005
Drug Interactions of HIV Protease Inhibitors
L. Malaty (1999)
10.7326/0003-4819-109-2-101
Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination.
A. Collier (1988)
10.4269/AJTMH.1995.53.448
Human Toxoplasma infection in Kuna and Embera children in the Bayano and San Blas, eastern Panama.
Etheredge Gd (1995)
10.1093/CLINIDS/22.5.809
Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin.
M. Falagas (1996)
10.4049/jimmunol.172.12.7229
Influence of Coinfecting Pathogens on HIV Expression: Evidence for a Role of Toll-Like Receptors1
A. Báfica (2004)
10.1016/0006-2952(92)90638-Y
Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs.
K. N. Bangchang (1992)
10.1086/340027
Suppression of human immunodeficiency virus replication during acute measles.
W. Moss (2002)
10.1097/00126334-200209010-00008
Treatment of Intestinal Worms Is Associated With Decreased HIV Plasma Viral Load
D. Wolday (2002)
10.1086/314031
Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.
M. Receveur (2000)
10.1086/514058
Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study.
R. Hershow (1997)
10.1086/324743
Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
P. Phillips (2002)
10.1086/338152
Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.
S. Ida (2002)
Invasive meningococcal disease and HIV coinfection.
Couldwell Dl (2001)
10.1001/JAMA.1992.03480090085032
Severe measles in immunocompromised patients.
L. J. Kaplan (1992)
Updated recommendations of the Advisory Committee on Immunization Practice (ACIP)
D R Prevots (2000)
10.1001/ARCHINTE.167.17.1827
Challenges in the prevention, diagnosis, and treatment of malaria in human immunodeficiency virus infected adults in sub-Saharan Africa.
P. Brentlinger (2007)
10.1196/annals.1355.047
Occurrence of Bartonella henselae and Bartonella quintana among Human Immunodeficiency Virus‐Infected Patients
M. Pape (2005)
10.1097/00002030-199903110-00009
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.
H. Bucher (1999)
OM: Prevalence of antibodies to Toxoplasma gondii among blood donors in Abha, Asir Region, southwestern Saudi Arabia
Al-Amari (1994)
Measles in hospitalized African children with HIV (letter)
M G Sension (1988)
10.1097/00006454-199211120-00004
Population-based study of measles and measles immunization in human immunodeficiency virus-infected children.
P. Palumbo (1992)
10.1097/00002030-199801000-00004
Impact of opportunistic disease on survival in patients with HIV infection
R. Chaisson (1998)
10.1097/00002030-199008000-00005
Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach.
N. Nagelkerke (1990)
10.1126/SCIENCE.276.5310.273
Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
R. Carroll (1997)
The burden of coinfection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa
FO ter Keuile (2004)
10.4269/AJTMH.2007.77.113
Neurocysticercosis in the HIV era: a case report and review of the literature.
J. Serpa (2007)
10.4269/AJTMH.1958.7.298
Intestinal protozoa and helminths in the peoples of Western (Anatolia) Turkey.
R. Kuntz (1958)
Reactivation of Chagas’ disease successfully treated with benznidazole in a patient with AIDS
S deANishioka (1993)
10.1128/AAC.37.11.2407
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
K. Supparatpinyo (1993)
10.1111/j.1468-1293.2007.00441.x
HIV‐associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV
M. Guiguet (2007)
10.1056/NEJMRA032588
Pneumocystis pneumonia.
C. Thomas (2004)
10.1097/00008480-200308000-00006
Sexually transmitted diseases treatment guidelines
G. Burstein (2003)
10.1016/S0169-4758(99)01497-0
Schistosomiasis of the female genital tract: public health aspects.
G. Poggensee (1999)
10.1016/S1473-3099(02)00263-3
Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.
U. Hengge (2002)
10.1016/S0140-6736(04)17140-7
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis
Marie‐Louise Newell (2004)
10.1093/INFDIS/163.6.1326
Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.
J. Ellner (1991)
10.1001/JAMA.260.11.1599
Concentration of Mycobacterium avium by hospital hot water systems.
G. Moulin (1988)
Klempner MS: Babesiosis in patients with AIDS: A chronic infection presenting as fever of unknown origin
ME Falagas (1996)
Respiratory syncytial virus pneumonia in a HIV-infected man (letter)
D Murphy (1989)
10.1046/j.1365-2133.2000.03480.x
Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus‐associated scabies
F. Alberici (2000)
10.1086/313610
Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1.
U. Thisyakorn (2000)
10.1128/CMR.9.4.435
Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.
M. Saubolle (1996)
The Lipophosphoglycan ofLeishmania donovaniUp-Regulates HIV-1 Transcription in T Cells Through the Nuclear Factor-kB Elements
R. Bernier (1998)
10.1097/00002030-199006000-00018
Toxoplasmic encephalitis.
P. Mariuz (1992)
10.1111/j.1365-4362.1992.tb03575.x
FATAL DISSEMINATED MYCOBACTERIUM MARINUM INFECTION
A. M. Tchornobay (1992)
10.1016/0090-1229(88)90055-4
Transient T-cell abnormality in a selective IgM-immunodeficient patient with Brucella infection.
S. Raziuddin (1988)
Effect of HIV infection on the course of syphilis.
G. Pialoux (2008)
10.1086/518167
Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
S. Antinori (2007)
10.1093/INFDIS/168.3.777
Isolation of Mycobacterium avium complex from bone marrow aspirates of AIDS patients in Brazil.
J. Barreto (1993)
10.1086/517068
Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan.
C. Hung (1998)
10.1172/JCI13603
Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection.
M. Slifka (2003)
Cysticercose envahissante à Taenia crassiceps chez un patient atteint de sida
R Chermette (1995)
Intestinal parasitic infections in HIV/AIDS and HIV seronegative individuals in a teaching hospital
G Hailemariam (2004)
10.4269/AJTMH.1992.47.133
The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire.
J. Pépin (1992)
10.1056/NEJM198706183162503
Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus.
D. Johns (1987)
10.1001/jama.1988.03720080019021
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
M. Fischl (1988)
Filarial infection increases susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro
R Gopinath (2000)
10.1016/0923-2508(92)90057-U
Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS.
J. McFadden (1992)
10.1097/00007435-200303000-00017
Sexual Behavior and Sexually Transmitted Infections in Men Living in Rural Madagascar: Implications for HIV Transmission
P. Leutscher (2003)
Endocrine abnormalities associated with HIV infection and AIDS
M Scharnbelan (1994)
10.1007/s100960100457
Relapsing Visceral Leishmaniasis in HIV-Infected Patients Undergoing Successful Protease Inhibitor Therapy
J. Casado (2001)
10.1093/INFDIS/163.3.454
Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection.
S. Hadler (1991)
Life-threatening bacteremia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
CF Gilks (1990)
10.4269/AJTMH.2004.71.41
The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa.
F. T. Ter Kuile (2004)
10.1097/00007611-199312000-00023
Ribavirin and intravenous immune globulin therapy for measles pneumonia in HIV infection.
S. W. Stogner (1993)
T cell function in vitro is an independent progression marker for AIDS in HIV-infected asymptomatic subjects
MTL Roos (1995)
Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases.
(1987)
10.1086/497696
Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load.
P. Kallestrup (2005)
10.1097/00002030-199211000-00013
Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity
C. Kemper (1992)
10.1097/01.aids.0000174445.40379.e0
The potential for interactions between antimalarial and antiretroviral drugs
S. Khoo (2005)
10.1097/00002030-199406000-00024
Could infected drug-users be potential Leishmania infantum reservoirs?
J. Alvar (1994)
10.1086/320886
Treatment of patients with refractory giardiasis.
T. Nash (2001)
10.1212/WNL.41.12.1993
Granulomatous amebic encephalitis in an AIDS patient
H. Gardner (1991)
10.1097/00019048-200206000-00012
SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES 2002
K. Workowski (2002)
10.1086/341248
Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia.
W. Moss (2002)
An uncommon cause of death in African patients with acquired immunodeficiency syndrome
YL Abouya (1992)
10.1097/00042560-199904010-00004
Trypanosoma cruzi meningoencephalitis in HIV-infected patients.
N. Silva (1999)
10.1016/S0065-2776(08)60185-6
Immunological phenomena in leprosy and related diseases.
J. Turk (1971)
10.1001/ARCHINTE.1993.00410050074010
Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis.
P. Brouqui (1993)
10.1080/00365549950161907
Generalized mycobacterium genavense infection in HIV-infected patients: detection of the mycobacterium in hospital tap water.
M. E. Hillebrand-Haverkort (1999)
10.1084/JEM.179.4.1361
Impaired interleukin 12 production in human immunodeficiency virus- infected patients
J. Chehimi (1994)
10.1016/0035-9203(93)90441-R
HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections.
L. Gradoni (1993)
10.1086/376987
Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study.
J. Canueto-Quintero (2003)
10.1016/0190-9622(90)70199-R
Hypereosinophilic syndrome with unusual cutaneous manifestations in two men with HIV infection.
L. P. May (1990)
Efficacy of sulfadoxinepyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection
ME Parise (1998)
10.1097/00006454-199712000-00015
Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.
T. Sibailly (1997)
10.1016/0002-9343(87)90656-5
Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome.
S. Ma'ayan (1987)
10.1093/CLINIDS/13.5.1005
Blastomycosis in Africa: clinical features, diagnosis, and treatment.
G. Baily (1991)
10.1097/00002030-199402000-00024
Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus.
R. Molina (1994)
10.1128/JCM.30.2.479-484.1992
Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates.
A. Y. Tsang (1992)
10.1046/j.1365-2249.2001.01401.x
Impact of tuberculosis (TB) on HIV‐1 activity in dually infected patients
Z. Toossi (2001)
10.1076/OCII.7.3.173.4002
The epidemiology of CMV retinitis in Africa.
P. Kestelyn (1999)
10.1086/375346
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.
L. Morris (2003)
10.1136/thx.49.4.370
Tropical respiratory medicine. 1. Pulmonary infections in the tropics: impact of HIV infection.
C. Daley (1994)
Nasal leishmaniasis in an HIVpositive patient
JM Grasa (2000)
Clinical study of HIV disease in the lower area of northern Thailand in 1994.
A. Swasdisevi (1994)
10.1086/313751
Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.
C. Kauffman (2000)
10.1001/jama.1988.03410110107037
Concentration of Mycobacterium avium by hospital hot water systems.
G. D. du Moulin (1988)
10.1016/0140-6736(91)91771-L
Child mortality after high-titre measles vaccines: prospective study in Senegal
M. Garenne (1991)
10.1097/00002030-199811000-00026
Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors.
V. le Moing (1998)
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific bacterial effect of BCG? Vaccine 21:2782
M L Garly (2003)
10.1128/JCM.37.1.117-121.1999
Diagnosis of Penicillium marneffeiInfection by Quantitation of Urinary Antigen by Using an Enzyme Immunoassay
V. Desakorn (1999)
Reappearance of hepatitis B virus in immune patients infected with HIV type 1
Y Lazizi (1988)
Anonymous: Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection
(1993)
10.1016/S0091-6749(97)70177-5
Objective measures of allergic disease in children with human immunodeficiency virus infection.
B. Bacot (1997)
10.1016/0016-5085(88)90557-4
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome.
B. Laughon (1988)
Mycobacterium marinum infection in a patient with cryptosporidiosis and the acquired immunodeficiency syndrome.
M. Lambertus (1988)
10.1016/S0140-6736(87)92896-0
AIDS AND STRONGYLOIDIASIS IN AFRICA
J. Petithory (1987)
The influence of HIV type 1 infection on the development of the hepatitis B virus carrier state
N J Bodsworth (1991)
10.1001/ARCHNEUR.57.1.114
St Louis encephalitis: a review of 11 cases in a 1995 Dallas, Tex, epidemic.
M. Wasay (2000)
10.1007/978-94-011-2980-0
Immunology of HIV Infection
A. Bird (1992)
Safety and immunogenicity of postexposure rabies vaccination in children infected with human immunodeficiency virus type 1
U Thisyakorn (2000)
10.1016/0962-8479(95)90584-7
Acute eosinophilic pneumonia in a patient infected with the human immunodeficiency virus.
J. Mayo (1995)
10.1097/00002030-199818000-00014
Twice weekly tuberculosis preventive therapy in HIV infection in Zambia
A. Mwinga (1998)
10.1016/S0035-9203(03)90157-X
Simulium neavei-transmitted onchocerciasis: HIV infection increases severity of onchocercal skin disease in a small sample of patients.
W. Kipp (2003)
10.1016/0035-9203(90)90452-K
Problems of chemotherapy in multiply-infected AIDS patients.
B. Gazzard (1990)
10.1016/S0140-6736(04)15645-6
Babesiosis and HIV
M. Froberg (2004)
10.1001/JAMA.1988.03720030020015
BCG vaccine abscesses are unrelated to HIV infection.
R. Colebunders (1988)
10.1128/JCM.31.12.3227-3230.1993
Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya.
C. F. von Reyn (1993)
[Neuropathology in acquired immune deficiency syndrome].
M. Dąmbska (1986)
10.4269/AJTMH.2003.69.420
Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
V. Mwanakasale (2003)
Clinical manifestations and implications of co-infection with Mycobacterium kansasii and HIV type 1
RS Witzig (1995)
Opportunistic infections in AIDS/HIV infected patients in Thailand
P Thongcharoen (1992)
10.1016/S0140-6736(95)91862-0
Pneumocystis carinii pneumonia in Zimbabwe
A. Malin (1995)
10.1097/00002030-199705000-00015
The risks and benefits of childhood bacille Calmette‐Guérin immunization among adults with AIDS
B. Marsh (1997)
10.1084/JEM.182.6.1727
Activation of virus replication after vaccination of HIV-1-infected individuals
S. Staprans (1995)
10.1093/CLINIDS/21.5.1197
Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.
F. Kroon (1995)
10.1016/S0140-6736(97)01474-8
HIV-1 disease progression and AIDS-defining disorders in rural Uganda
D. Morgan (1997)
10.1172/JCI119318
HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28.
M. Roederer (1997)
10.1258/0956462971918760
Travels with HIV: the compliance and health of HIV-infected adults who travel
C. Kemper (1997)
10.1093/CLINIDS/21.1.77
Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
R. S. Witzig (1995)
UNAIDS: AIDS epidemic update
(2004)
10.1080/369378031000137215
Paracoccidioidomycosis associated with human immunodeficiency virus infection
M. Silva-Vergara (2003)
10.1517/14656566.6.3.385
Pharmacological management of paracoccidioidomycosis.
M. Yasuda (2005)
10.1016/S0035-9203(96)90488-5
Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
S. Tawill (1996)
Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals.
O. Shapira-Nahor (1998)
Histoplasmose africaine: Aspects cliniques et thérapeutiques-relations avec le SIDA
L Geffray (1994)
Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in co-infected cultures
H Asada (1999)
Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with HIV
J. Dumonceau (1995)
10.4049/jimmunol.172.5.3086
Leishmania infantum Promotes Replication of HIV Type 1 in Human Lymphoid Tissue Cultured Ex Vivo by Inducing Secretion of the Proinflammatory Cytokines TNF-α and IL-1α1
Chenqi Zhao (2004)
10.1016/S0009-9236(96)90019-3
Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine
B. Lee (1996)
10.1093/INFDIS/158.2.480
Fatal measles pneumonia without rash in a child with AIDS.
L. Markowitz (1988)
10.1046/j.1365-3083.1999.00467.x
Relationship Between Interleukin‐5 Production and Variations in Eosinophil Counts During HIV Infection in West Africa: Influence of Mycobacterium tuberculosis Infection
S. Diagbouga (1999)
10.1016/J.DIAGMICROBIO.2006.08.011
Identification of Acanthamoeba sp. in paraffin-embedded CNS tissue from an HIV+ individual by PCR.
R. MacLean (2007)
10.1093/INFDIS/168.3.564
Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, west Africa.
D. Vugia (1993)
10.1038/nrmicro1245
Deciphering the Model Pathogenic Fungus Cryptococcus Neoformans
A. Idnurm (2005)
Incidence of Mycobacterium avium–intracellulare complex bacteremia in HIVpositive patients
SD Nightingale (1992)
10.1172/JCI116372
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.
C. Karp (1993)
Complement-fixing antibodies against cytomegalovirus in different parts of the world.
U. Krech (1973)
10.1309/HF2V-E8WV-PX4Q-CHQH
Clinical and pathologic features of Mycobacterium fortuitum infections. An emerging pathogen in patients with AIDS.
M. Smith (2001)
Le syndrome d’immunodéficience acquise (SIDA) à Kinshasa, Zaire: Observations cliniques et épidémiologiques
W Odio (1985)
10.1093/INFDIS/174.2.401
Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons.
R. Donovan (1996)
10.1136/bmj.298.6670.364
Prevalence of HIV infection among patients with leprosy and tuberculosis in rural Zambia.
K. Meeran (1989)
Failure of multiplesite intradermal postexposure rabies vaccination in patients infected with human immunodeficiency virus with low CD4+ lymphocyte counts
T Tantawichen (2001)
10.1093/JAC/DKH084
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
R. López-Vélez (2004)
10.1016/0090-3019(95)00259-6
Neurocysticercosis and HIV infection: report of two cases and review.
J. L. Soto Hernandez (1996)
10.1016/J.TRSTMH.2007.02.009
Co-infection with subclinical HIV and Wuchereria bancrofti, and the role of malaria and hookworms, in adult Tanzanians: infection intensities, CD4/CD8 counts and cytokine responses.
N. Nielsen (2007)
Prevalence of measles antibodies in asymptomatic HIV-infected adults
B E Sha (1991)
10.1097/00006454-199107000-00014
Measles giant cell pneumonia in a child with human immunodeficiency virus infection.
S. Nadel (1991)
10.1016/0035-9203(92)90102-I
Intestinal parasites in Zambian patients with AIDS.
G. Hunter (1992)
10.4269/AJTMH.1998.59.307
Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.
D. M. Karanja (1998)
10.1097/00002030-200011100-00004
The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals
S. Lawn (2000)
10.1097/00126334-199205000-00007
Absence of Mycobacterium avium complex disease in patients with AIDS in Uganda.
A. Morrissey (1992)
10.1086/427295
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
L. Mofenson (2004)
10.1007/s004010050538
Rabies encephalitis in a patient with AIDS: a clinicopathological study
H. Adle-Biassette (1996)
10.1093/CLINIDS/17.SUPPLEMENT_2.S487
Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management.
S. Vartivarian (1993)
10.1093/CLINIDS/23.3.563
Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution.
V. Singh (1996)
10.1080/00034980057590
Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases.
E. Rosenthal (2000)
10.1093/CLIND/16.2.255
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
A. Solari (1993)
10.3201/eid1003.030971
Q Fever Endocarditis in HIV-Infected Patient
M. Madariaga (2004)
Treatment of HIV-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
(1998)
Isolation of Mycobacterium celatum from patients infected with HIV
C Piersimoni (1997)
10.1086/507310
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria.
J. Van Geertruyden (2006)
10.1093/CLINIDS/13.6.1163
The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.
S. Levitz (1991)
10.1542/PEDS.103.5.1057
Measles Immunization in HIV-Infected Children
N. Halsey (1999)
10.1080/02681219680000671
Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei.
N. Kudeken (1996)
Alveolar echinococcosis of the liver in a six-year-old girl with AIDS
M Sailer (1997)
10.1016/S0140-6736(04)17017-7
History of thymoma and yellow fever vaccination
R. Eidex (2004)
10.1086/514701
Cryptosporidiosis in patients with AIDS: correlates of disease and survival.
Y. Manabe (1998)
10.1128/AAC.00840-06
Synergistic Interactions of the Antiretroviral Protease Inhibitors Saquinavir and Ritonavir with Chloroquine and Mefloquine against Plasmodium falciparum In Vitro
T. Skinner-Adams (2006)
10.1007/S11908-005-0073-2
Sexually transmitted diseases in travelers
N. Hynes (2005)
Disseminated parasitosis in an immunosuppressed patient. Possibly a mutated sparganum.
D. Connor (1976)
10.1016/S0140-6736(84)91356-4
IMMUNOGLOBULIN PROPHYLAXIS OF MEASLES IN ACUTE LYMPHOBLASTIC LEUKAEMIA
H. Kay (1984)
[Nasal leishmaniasis in an HIV-positive patient].
J. M. Grasa (2000)
10.1086/513647
Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses.
J. Wheat (1997)
10.1016/0035-9203(93)90119-B
Prevalence of enteric viruses among hospital patients with AIDS in Kinshasa, Zaire
D. M. Thea (1993)
10.1016/S1473-3099(04)01061-8
Syphilis and HIV: a dangerous combination.
W. Lynn (2004)
10.1093/INFDIS/163.5.1138
The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state.
N. Bodsworth (1991)
Current trends: Adverse reaction to Fansidar and updated recommendations for its use in the prevention of malaria
(1985)
10.1128/JCM.31.3.754-757.1993
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.
C. Lee (1993)
10.1128/CMR.10.2.298
Leishmania and human immunodeficiency virus coinfection: the first 10 years.
J. Alvar (1997)
10.5935/0305-7518.19920017
Clinical observations on leprosy patients with HIV1-infection in Zambia.
A. Vreeburg (1992)
10.1056/NEJM199412013312201
The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection.
S. Gordon (1994)
10.1086/520144
Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival.
C. Staples (1999)
Anonymous: Preventive therapy against tuberculosis in people living with HIV
(1999)
10.1258/0956462961918419
Sex and travel: studies of sexual behaviour, disease and health promotion in international travellers--a global review.
B. Mulhall (1996)
10.1093/infdis/174.3.615
Eosinophilia in patients infected with human immunodeficiency virus.
A. J. Cohen (1996)
FG: In vitro and in vivo effects of itraconazole against Trypanosoma cruzi
RE McCabe (1986)
Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen.
M. Kullberg (1992)
10.1016/0046-8177(92)90054-7
Epstein-Barr virus and interleukin-5 mRNA in acquired immunodeficiency syndrome-related lymphomas with eosinophilia.
M. Samoszuk (1992)
10.4269/AJTMH.1995.52.546
Toxoplasma gondii antibodies in pregnant women and their newborns in Dar es Salaam, Tanzania.
E. Doehring (1995)
10.1001/JAMA.1996.03540020008003
Penicillium marneffei part of Southeast Asian AIDS.
P. Phillips (1996)
10.1007/BF02098468
Coxiella burnetii infection among subjects infected with HIV type 1 in the Central African Republic
L. Bélec (2005)
10.1056/NEJM199812103392403
A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus.
K. Supparatpinyo (1998)
10.1093/CLINIDS/21.SUPPLEMENT_1.S94
Infections associated with Bartonella species in persons infected with human immunodeficiency virus.
R. Regnery (1995)
10.1080/00365540701474508
Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia
G. Aderaye (2007)
10.1016/S1473-3099(06)70493-5
Interactions between HIV infection and leprosy: a paradox.
A. Ustianowski (2006)
10.1053/JINF.2000.0696
Current approach to the acute management of cryptococcal infections.
W. Powderly (2000)
10.1093/CLINIDS/19.3.454
Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin.
A. Forni (1994)
10.1093/CLINIDS/18.3.475
Successful treatment of disseminated Mycobacterium haemophilum infection in a patient with AIDS.
A. Soubani (1994)
10.1097/00002030-200403260-00020
Yellow fever vaccine is safe and effective in HIV-infected patients
P. Tattevin (2004)
10.1001/ARCHDERM.140.8.997
Immune reconstitution inflammatory syndrome associated with HIV and leprosy.
P. Couppié (2004)
10.1093/CLINIDS/13.5.789
Mycobacterium kansasii infections in patients positive for human immunodeficiency virus.
J. Carpenter (1991)
10.1093/CLINIDS/21.SUPPLEMENT_1.S84
Bacterial enteric infections in persons infected with human immunodeficiency virus.
F. Angulo (1995)
10.1136/bmj.317.7159.625
Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials
D. Wilkinson (1998)
10.1007/s003300000606
Mycobacterium genavense infection in AIDS: imaging findings in eight patients
J. Monill (2001)
Indirect xenodiagnosis of visceral leishmaniasis in ten patients with HIV infection using colonized Phlebotomus perniciosus
R Molina (1994)
10.1016/0035-9203(94)90277-1
Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi.
T. Taha (1994)
10.1097/00007611-199207000-00025
Right middle lobe syndrome caused by Mycobacterium fortuitum in a patient with human immunodeficiency virus infection.
G. W. Lambert (1992)
10.7326/0003-4819-114-10-861
Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
B. Levine (1991)
10.1179/000349803225002552
Lower trypanosomatids in HIV/AIDS patients
C. Chicharro (2003)
10.7326/0003-4819-121-9-199411010-00004
Cyclospora Infection in Adults Infected with HIV: Clinical Manifestations, Treatment, and Prophylaxis
J. Pape (1994)
Haemoculture as a tool for diagnosing visceral leishmaniasis in HIV-negative and HIV-positive patients: interest for parasite identification.
J. Dereure (1998)
10.1016/S0002-9343(99)80105-3
Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy.
J. L. Malone (1995)
10.1111/j.1439-0507.1991.tb00620.x
African histoplasmosis in a Belgian AIDS patient
V. Arendt (1991)
10.1086/520282
Hepatic penicilliosis in patients without skin lesions.
P. Kantipong (1998)
HIV-1 infection as a risk factor for leprosy; a case-control study in Tanzania.
M. Borgdorff (1993)
10.1111/j.1468-3083.1998.tb00739.x
American cutaneous leishmaniasis associated with HIV infection: report of four cases
M. Mattos (1998)
The risks and benefits of childhood bacille Calmette – Guérin immunization among adults with
ML Garly (1997)
10.1016/S0140-6736(94)91771-X
Serodiagnosis of Penicillium marneffei infection
K. Yuen (1994)
10.1086/321009
Natural measles causes prolonged suppression of interleukin-12 production.
S. F. Atabani (2001)
10.1159/000200687
Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection.
I. Castillo (1991)
Acanthamoeba meningoencephalitis in a patient with acquired immunodeficiency syndrome.
C. Di Gregorio (1992)
10.1093/INFDIS/167.5.1243
Geographic variation in the humoral response to Pneumocystis carinii.
A. Smulian (1993)
Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians.
D. Wolday (2003)
10.1016/S0140-6736(04)16354-X
Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection
Adele M. Mount (2004)
10.1097/00002030-200106150-00019
HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children.
M. Kamya (2001)
10.1128/IAI.67.10.5258-5264.1999
Role of Leishmania donovani and Its Lipophosphoglycan in CD4+ T-cell Activation-Induced Human Immunodeficiency Virus Replication
D. Wolday (1999)
10.1016/0002-9343(89)90290-8
Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome.
O. Armignacco (1989)
10.1007/BF00436865
Cryptococcus neoformàns var. gattii among patients with cryptococcal meningitis in Mexico. First observations
R. López-Martínez (2004)
10.1097/00002030-199903110-00007
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration.
I. Hoffman (1999)
10.7326/0003-4819-118-5-199303010-00005
Effects of HIV Infection on the Serologic Manifestations and Response to Treatment of Syphilis in Intravenous Drug Users
M. Gourevitch (1993)
Pneumocystoses observées au Congo chez les malades atteints de SIDA
J M’boussa (1991)
10.1097/00005792-199011000-00004
Disseminated Histoplasmosis in the Acquired Immune Deficiency Syndrome: Clinical Findings, Diagnosis and Treatment, and Review of the Literature
L. Wheat (1990)
10.1093/IJE/17.4.705
Investigating interactions between HIV infection and tropical diseases.
P. Smith (1988)
10.1016/S0140-6736(00)04639-0
Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1
A. Harries (2001)
Coxiella burnetii infection among HIV-1infected people living in Paris, France (letter)
L Bélec (1993)
Joint WHO/UNAIDS/UNICEF statement on use of cotrimoxazole as prophylaxis in HIV exposed and HIV infected children
WhoUnaidsUnicef (2004)
10.1093/CLIND/15.6.1024
Culture isolation of Acanthamoeba species and leptomyxid amebas from patients with amebic meningoencephalitis, including two patients with AIDS.
S. Gordon (1992)
10.1086/514536
Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review.
V. Dunand (1997)
10.1073/PNAS.93.23.13194
Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.
J. Schlender (1996)
10.1002/HEP.1840150404
Interactions between human immunodeficiency virus‐1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus
C. Housset (1992)
10.1016/S0140-6736(07)60082-8
Achieving the goal for global measles mortality
D. Elliman (2007)
HIV–Leishmania co-infections in Italy: Serological data as an indication of the sequence of the two infections
L Gradoni (1993)
Similar serologic response to conventional therapy for syphilis among HIV-positive and HIVnegative women
J Goeman (1995)
10.1086/374930
Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis.
S. Springer (2003)
10.1086/517241
Postexposure rabies vaccination in patients infected with human immunodeficiency virus.
W. Jaijaroensup (1999)
Population-based study of measles and measles immunization in HIV-infected children
P Palumbo (1992)
10.1016/B978-141602613-6.10014-X
Chapter 14 – Travel and HIV Infection
Susan L. F. Mclellan (2008)
10.1093/JAC/32.4.657
Efficacy of liposomal amphotericin B in the treatment and secondary prophylaxis of visceral leishmaniasis in HIV infected patients: report of two cases.
M. López Dupla (1993)
Mycobacterium kansasii disease in patients infected with HIV
RE Campo (1997)
CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells
R Zhang (2004)
[Pulmonary site of visceral leishmaniasis in HIV infection].
P. Heudier (1993)
10.1093/CLINIDS/18.2.246
Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection.
K. Supparatpinyo (1994)
10.1093/CLINIDS/13.5.906
Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature.
M. Kristjánsson (1991)
10.1590/S0074-02762004000900016
Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya.
W. Secor (2004)
10.4269/AJTMH.1997.56.515
Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections.
D. M. Karanja (1997)
10.1080/02681219280000301
Disseminated African histoplasmosis in a Congolese patient with AIDS.
B. Carme (1992)
10.1097/00002030-200203080-00011
HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?
D. Morgan (2002)
Centers for Disease Control and Prevention: Preventing cryptosporidiosis: A guide to water filters and bottled water
R Colebunders (1999)
10.1056/nejm198109103051102
Sexual transmission of enteric protozoa and helminths in a venereal-disease-clinic population.
S. Phillips (1981)
Anonymous: Update: Acquired immunodeficiency syndrome (AIDS) in the United States
R M Genta (1982)
10.1056/NEJM199307013290103
Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working Group.
G. Grohmann (1993)
10.1093/INFDIS/168.6.1553
Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.
C. F. von Reyn (1993)
10.1111/J.1469-0691.2003.00745.X
Relapsing brucellosis in a patient infected with the human immunodeficiency virus (HIV).
V. Ibarra (2003)
10.1016/0035-9203(95)90497-2
Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus.
N. Berhe (1995)
Anonymous: Disseminated infection with simiae-avium group mycobacteria in persons with AIDS-Thailand and Malawi
D Huminer (1993)
Right middle lobe syndrome caused by Mycobacterium fortuitum in a patient with HIV infection
GW Lambert (1992)
10.1111/J.1574-695X.2007.00232.X
Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
G. Visvesvara (2007)
10.1007/BF02111494
Mycobacterium genavense: An emerging pathogen
E. Böttger (2005)
10.7326/0003-4819-123-12-199512150-00007
Sporadic Meningococcal Disease in Adults: Results of a 5-Year Population-Based Study
D. Stephens (1995)
10.1086/516356
Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection.
J. Al-Tawfiq (1998)
Acquired immunodeficiency syndrome associated with Acanthamoeba infection and other opportunistic organisms.
M. M. González (1986)
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with HIV infection
DP Chin (1994)
10.1016/S0140-6736(97)06532-X
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
N. Halsey (1998)
10.7326/0003-4819-121-9-199411010-00006
Isospora belli Infection Associated with Acalculous Cholecystitis in a Patient with AIDS
D. Benator (1994)
10.4269/AJTMH.1996.55.42
Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.
R. Steketee (1996)
10.1093/CLINIDS/20.3.549
Disseminated Mycobacterium scrofulaceum infection: a potentially treatable complication of AIDS.
J. Sanders (1995)
The pathology of severe morbidity and mortality caused by HIV infection in Africa.
S. Lucas (1991)
Amebic meningoencephalitis in a patient with AIDS caused by a newly recognized opportunistic pathogen. Leptomyxid ameba.
A. Anzil (1991)
10.1016/S0140-6736(04)17442-4
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial
C. Chintu (2004)
10.1056/NEJM198810273191704
Human immunodeficiency virus infection among employees in an African hospital.
B. N'galy (1988)
Prevalence of antibodies to Toxoplasma gondii among blood donors in Abha, Asir Region, south-western Saudi Arabia.
O. al-Amari (1994)
10.1179/000349803225002507
Leishmania/HIV co-infection in Brazil: an appraisal
A. Rabello (2003)
Mycobacterium kansasii : A cause of treatable pulmonary disease associated with advanced HIV infection
B Levine (1991)
10.7326/0003-4819-106-3-372
Coccidioidomycosis in the acquired immunodeficiency syndrome.
D. Bronnimann (1987)
10.1164/AJRCCM.155.1.9001290
Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
J. Stansell (1997)
10.1086/520178
Human immunodeficiency virus infection, anemia, and survival.
R. Moore (1999)
10.1097/00007611-199404000-00021
A Hypereosinophilic Syndrome Associated with HIV Infection
J. Drabick (1992)
10.1093/INFDIS/163.6.1201
Syphilis, neurosyphilis, penicillin, and AIDS.
D. Musher (1991)
10.1590/S0042-96862003000100012
Immunization of children at risk of infection with human immunodeficiency virus.
W. Moss (2003)
10.1097/00002030-200209270-00008
IMMUNE RECOVERY IS ASSOCIATED WITH PERSISTENT RISE IN HEPATITIS C VIRUS RNA, INFREQUENT LIVER TEST FLARES, AND IS NOT IMPAIRED BY HEPATITIS C VIRUS IN CO-INFECTED SUBJECTS
R. Chung (2002)
10.1093/CLINIDS/24.2.144
Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus.
C. Piersimoni (1997)
Absence of epidemiological inter-relations between HIV infection and African human trypanosomiasis in central Africa.
J. P. Louis (1991)
10.1016/J.TRSTMH.2005.08.016
Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania.
N. Nielsen (2006)
10.1128/JVI.74.10.4505-4511.2000
Inhibition of Human Immunodeficiency Virus Type 1 Replication prior to Reverse Transcription by Influenza Virus Stimulation
L. Pinto (2000)
10.1016/0035-9203(87)90377-4
Absence of relationship between human immunodeficiency virus 1 and sleeping sickness.
F. Noireau (1987)
10.1086/504380
Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection.
P. Kallestrup (2006)
10.1016/S0022-3476(97)70364-0
Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome.
M. Sailer (1997)
10.1016/S0140-6736(94)91287-4
Disseminated Penicillium marneffei infection in Southeast Asia
K. Supparatpinyo (1994)
10.1097/00002030-199310000-00009
Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy
M. Bessesen (1993)
10.1016/s0140-6736(64)91644-7
THE SIMIAN CREASE.
J. Sebus (1964)
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV patients
L Weiss (2004)
10.1111/j.0141-9838.2004.00733.x
The immuno‐epidemiology of pregnancy‐associated Plasmodium falciparum malaria: a variant surface antigen‐specific perspective
L. Hviid (2004)
10.1016/S0140-6736(02)09781-7
Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study
D. M. Karanja (2002)
10.1016/0035-9203(90)90306-Y
The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection.
O. Müller (1990)
[HIV-associated Penicillium marneffei infection].
C. Kronauer (1993)
10.1093/CLINIDS/24.2.226
Mycobacterium xenopi: innocent bystander or emerging pathogen?
T. Jiva (1997)
Respiratory syncytial virus illnesses in human immunodeficiency virus-infected and -noninfected children
J C King (1993)
10.1097/00002030-199103000-00015
Disseminated strongyloidiasis in AIDS: uncommon but important.
M. Gompels (1991)
Effect of HIV on hepatitis C virus infection among injecting drug users
D L Thomas (1996)
10.1097/00006454-199603000-00003
Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children.
J. C. King (1996)
10.1002/JMV.10139
Detection and characterisation of human astroviruses in children with acute gastroenteritis in Blantyre, Malawi
N. Cunliffe (2002)
10.1128/AAC.30.6.955
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.
C. Horsburgh (1986)
10.1016/0190-9622(92)70054-J
Diagnosis of Acanthamoeba infection by cutaneous manifestations in a man seropositive to HIV.
L. P. May (1992)
10.1136/sti.71.5.275
Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women.
J. Goeman (1995)
Fatal seronegative ehrlichiosis in a patient with HIV infection
CD Paddock (1993)
10.1016/S0140-6736(06)68541-3
Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study
J. Mermin (2006)
10.1093/CLINIDS/18.3.455
Disseminated Mycobacterium genavense infection in two patients with AIDS.
C. D. Gaynor (1994)
10.1073/PNAS.91.25.11811
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis.
M. Clerici (1994)
10.1182/BLOOD-2004-01-0365
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.
L. Weiss (2004)
10.1086/520651
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
L. Aurpibul (2007)
10.1097/00002030-198901001-00012
Interactions of HIV infection with endemic tropical diseases
R. Morrow (1989)
Measles and measles immunity in children infected with HIV
K Krasinski (1989)
patients in Kinshasa , Zaire
J delAmo (1989)
10.1086/425935
Why does HIV infection not lead to disseminated strongyloidiasis?
M. Viney (2004)
Response of human immunodeficiency virus-infected adults to measles-rubella vaccination.
M. A. Sprauer (1993)
10.1086/519169
Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
W. Moss (2007)
Plasmodium falciparum antigeninduced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-a
L Xiao (1998)
10.1368/1066-5234(2003)050[0531:CSAGIH]2.0.CO;2
Cryptosporidium Species and Genotypes in HIV-Positive Patients in Lima, Peru
V. Cama (2003)
10.1016/0035-9203(91)90034-V
Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus.
Alimuddin Zumla (1991)
10.1016/S0140-6736(00)02727-6
Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study
J. Whitworth (2000)
10.1164/AJRCCM/145.3.617
Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome.
Y. L. Abouya (1992)
10.1097/00042560-199504000-00010
CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis.
D. Martin (1995)
10.1164/AJRCCM.164.1.2101133
Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.
W. Burman (2001)
AIDS commentary. Toxoplasmic encephalitis.
B. Luft (1988)
10.1016/S0140-6736(00)02557-5
HIV-1 suppression during acute scrub-typhus infection
G. Watt (2000)
10.1093/OXFORDJOURNALS.QJMED.A068646
The presentation and outcome of HIV-related disease in Nairobi.
C. Gilks (1992)
Anonymous: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
(1987)
10.1001/JAMA.1989.03420080061014
Respiratory syncytial virus pneumonia in a human immunodeficiency virus-infected man.
D. Murphy (1989)
Taenia crassiceps cysticercosis and
H Maillard (1998)
10.1016/0035-9203(91)90167-W
Pneumocystis carinii is rare in AIDS in Central Africa.
B. Carme (1991)
10.1086/425042
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
M. Brown (2004)
Comparative demographic and autopsy findings in acquired immune deficiency syndrome in two Mexican populations.
J. Jessurun (1990)
10.1128/JCM.38.10.3892-3895.2000
Granulomatous Amebic Encephalitis in a Patient with AIDS: Isolation of Acanthamoeba sp. Group II from Brain Tissue and Successful Treatment with Sulfadiazine and Fluconazole
M. Seijo Martínez (2000)
10.1056/NEJM199107113250206
Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children.
A. Greenberg (1991)
10.1093/CLINIDS/19.1.48
Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review.
F. Laguna (1994)
Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors.
A. Sarin (1994)
10.1086/522180
Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens.
C. Karp (2007)
10.1111/J.1574-6968.1995.TB07496.X
Heterogeneity among zymodemes of Leishmania infantum from HIV-positive patients with visceral leishmaniasis in south Italy.
M. Gramiccia (1995)
10.4269/AJTMH.2001.65.810
Preventing opportunistic infections among human immunodeficiency virus-infected adults in African countries.
A. Grant (2001)
10.1111/j.1365-4362.1995.tb03592.x
VISCERAL LEISHMANIASIS WITH CUTANEOUS AND RECTAL DISSEMINATION DUE TO LEISHMANIA BRAZILIENSIS IN ACQUIRED IMMUNODEEICIENCY SYNDROME (AIDS)
D. Hernåndez (1995)
10.1016/S0190-9622(99)70342-7
Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection.
R. Colebunders (1999)
10.1136/sti.2006.021402
Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics
K. Ghanem (2007)
10.1097/00002030-200403260-00021
Coronavirus infection in an AIDS patient.
A. T. Y. Wong (2004)
10.1016/0002-9343(85)90458-9
Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome.
B. Wong (1985)
10.7326/0003-4819-109-11-855
Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.
S. Lukehart (1988)
10.1097/00002030-200112070-00013
HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case–control study
P. Francesconi (2001)
10.4269/AJTMH.1986.35.280
In vitro and in vivo effects of itraconazole against Trypanosoma cruzi.
R. Mccabe (1986)
10.1164/AJRCCM/139.1.4
The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).
Horsburgh Cr (1989)
10.1126/science.272.5265.1167
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
J. Mellors (1996)
10.1128/CMR.10.1.19
Biology of Isospora spp. from humans, nonhuman primates, and domestic animals.
D. Lindsay (1997)
Cryptococcus neoformans var. gatti among patients with cryptococcal meningitis in Mexico
R Lopez-Martinez (1996)
Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998.
N. Ansari (2002)
Natural history and clinical presentation of HIV-1 infection in adults.
R. Colebunders (1991)
10.1590/S0037-86821990000400009
[Leptospirosis in patients with anti-HIV antibodies: report of 2 cases].
M. V. D. da Silva (1990)
10.1016/S0002-9343(97)89503-4
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
E. Ribera (1996)
In vivo cytokine profiles in patients with kala azar. Marked elevation of both IL-10 and IFN-γ
CL Karp (1993)
10.1097/00002030-199302000-00001
The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS.
A. Weltman (1993)
10.1080/00034983.1996.11813056
Fulminant, systemic strongyloidiasis in AIDS.
K. Cahill (1996)
10.1136/sti.78.1.76
Immune reconstitution eosinophilia due to schistosomiasis
R. Fernando (2002)
10.1097/00002030-198902000-00004
The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire.
P. Desmet (1989)
Infection by human immunodeficiency virus-1 is not a risk factor for amebiasis.
C. Hung (2006)
Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
M. Badri (2001)
10.4269/AJTMH.2007.76.549
Prevalence of enteric protozoa in human immunodeficiency virus (HIV)-positive and HIV-negative men who have sex with men from Sydney, Australia.
D. Stark (2007)
10.1093/CLINIDS/15.2.211
Toxoplasmic encephalitis in AIDS.
B. Luft (1992)
10.1037/e547712006-001
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
J. Watson (1998)
10.1093/CLINIDS/17.6.1065
Respiratory syncytial virus infection in an adult with AIDS.
S. Sriskandan (1993)
Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.
Kitisak Kengsakul (2002)
RE: Mycobacterium kansasii: A cause of treatable pulmonary disease associated with advanced HIV infection
B Levine (1991)
10.1086/516257
Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients.
A. Sartori (1998)
The epidemiology of disseminated nontuberculous Mycobacterium infection in AIDS
Horsburgh CR (1989)
Diffusely disseminated cutaneous Leishmania major
D Gillis (1995)
The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements.
R. Bernier (1998)
Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.
P. Volkow (1993)
Sporotrichosis in patient with AIDS: report of a case and review.
M. M. Rocha (2001)
10.1016/S0022-3476(05)80539-6
Respiratory syncytial virus infection in human immunodeficiency virus-infected children.
S. Chandwani (1990)
: Uncommon but important
JN Harcourt-Webster (1991)
10.1093/CLIND/16.5.654
Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature.
M. Mustafa (1993)
Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of co-infection with HIV
M E Eyster (1993)
10.4049/jimmunol.168.12.6388
Inhibition of CXCR4-Tropic HIV-1 Infection by Lipopolysaccharide: Evidence of Different Mechanisms in Macrophages and T Lymphocytes1
A. Verani (2002)
10.1056/NEJM198607103150203
Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome.
J. Dehovitz (1986)
10.1093/INFDIS/164.5.973
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults.
B. Sha (1991)
10.1126/SCIENCE.8023142
Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells.
E. Maggi (1994)
10.1093/CLIND/16.4.540
Extrapulmonary and disseminated infections due to Mycobacterium malmoense: case report and review.
M. Zaugg (1993)
10.1016/S0190-9622(96)90079-1
Atypical scabies in HIV-positive patients.
J. J. Portu (1996)
10.1055/S-2008-1062291
[Taenia crassiceps infection in AIDS].
H. Klinker (1992)
10.1093/CLINIDS/21.SUPPLEMENT_1.S12
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
J. Kaplan (1995)
10.1086/517297
The impact of active herpes simplex virus infection on human immunodeficiency virus load.
L. Mole (1997)
10.1179/000349803225002615
The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV
R. López-Vélez (2003)
10.1002/jlb.64.5.642
IL‐4 and a glucocorticoid up‐regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV‐1 replication
J. Wang (1998)
10.1097/00002030-200402200-00023
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa
K. Grimwade (2004)
10.1002/HEP.1840070109
The influence of HTLV‐III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers
K. Krogsgaard (1987)
10.1046/j.1365-3156.1999.00349.x
Increased prevalence of malaria in HIV‐infected pregnant women and its implications for malaria control
F. H. Verhoeff (1999)
10.1016/0035-9203(90)90453-L
Missing infections in AIDS.
S. Lucas (1990)
10.1097/00042560-199601010-00010
Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand.
D. Kitayaporn (1996)
10.1086/422456
Concurrent cerebral american trypanosomiasis and toxoplasmosis in a patient with AIDS.
T. W. Yoo (2004)
10.1016/S0163-4453(88)97700-6
Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus.
T. Peto (1988)
10.4269/AJTMH.1998.59.155
The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1.
F. Medrano (1998)
10.1084/jem.20051970
CCR5 deficiency increases risk of symptomatic West Nile virus infection
W. G. Glass (2006)
10.1111/J.1365-2125.1994.TB05707.X
In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.
D. Birkett (1994)
10.1086/514744
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
D. McKinsey (1999)
10.4269/AJTMH.2006.74.1016
Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan.
Jih-Jin Tsai (2006)
Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children adolescents and adults. Recommendations for a public health approach.
Bpharm Ms (2006)
10.1097/00002030-200012010-00023
No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients.
E. F. Schippers (2000)
10.1093/INFDIS/161.2.296
Serologic responses to Pneumocystis carinii antigens in health and disease.
S. L. Peglow (1990)
10.1086/374562
Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.
C. Kemper (2003)
10.1093/CLINIDS/22.SUPPLEMENT_2.S112
The new fungal opportunists are coming.
J. Perfect (1996)
10.1136/gut.29.12.1687
Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study.
R. Colebunders (1988)
Antibodies to HIV-1 in sera from patients with mycobacterial infections.
L. Shivraj (1988)
10.1001/JAMA.284.4.450
The natural history of hepatitis C virus infection: host, viral, and environmental factors.
D. Thomas (2000)
10.1007/s10096-004-1131-7
Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy
P. Pignataro (2004)
10.1128/CMR.5.4.345
Dysregulation of strongyloidiasis: a new hypothesis.
R. Genta (1992)
10.1067/MIC.2002.130391
Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force.
J. Boyce (2002)
Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
G. Cathomas (2003)
10.1016/S0140-6736(00)02377-1
23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
N. French (2000)
10.1097/00002030-199812000-00019
Taenia crassiceps cysticercosis and AIDS.
H. Maillard (1998)
10.1016/J.IJID.2004.10.006
Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome.
P. Mootsikapun (2006)
10.1056/NEJM198703053161015
Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV.
R. Biggar (1987)
10.1016/S0264-410X(97)00275-2
Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.
S. Tasker (1998)
10.1007/BF01974645
Two cases of laryngeal leishmaniasis in patients infected with HIV
M. I. González-Anglada (2005)
10.1097/00006454-199205000-00012
Disseminated Acanthamoeba infection in a child with symptomatic human immunodeficiency virus infection
L. Friedland (1992)
10.1097/00002030-200207260-00012
Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi
A. Crampin (2002)
10.1037/e451622006-001
Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
R. Harpaz (1996)
10.1086/318135
HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania.
E. Rosenthal (2000)
10.1093/CLINIDS/14.5.1164
Hyperkeratotic (Norwegian) scabies with gram-negative bacteremia as the initial presentation of AIDS.
T. Hulbert (1992)
Rifampin and pyrazinamide vs. isoniazid for prevention of tuberculosis in HIV-infected persons
F Gordin (2000)
10.1086/513649
Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand.
S. Chariyalertsak (1997)
Ministerio da Saude do Brasil: Dados e pesquisa em DST e AIDS. Coordenacao do programa nacional de DTS/AIDS. Brasilia
(2002)
10.1093/JAC/DKG356
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
F. Laguna (2003)
10.1016/J.TRSTMH.2004.01.011
The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand.
W. Chierakul (2004)
10.4269/AJTMH.2001.65.623
Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya.
A. V. van Eijk (2001)
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture.
D. Kwiatkowski (1989)
10.1136/bmj.311.7018.1468
Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years
T. Perneger (1995)
10.1093/CLINIDS/14.6.1229
Disseminated infection with Mycobacterium gordonae: report of a case and critical review of the literature.
M. Weinberger (1992)
10.1097/01.MP.0000027203.44333.95
Lymphadenopathy Due to Penicillium Marneffei Infection: Diagnosis by Fine Needle Aspiration Cytology
B. Chaiwun (2002)
10.1097/00002030-199910010-00015
HIV viral load and response to antileishmanial chemotherapy in co-infected patients.
N. Berhe (1999)
Leprosy and infection with the human immunodeficiency virus in Uganda; a case-control study.
H. J. Kawuma (1994)
10.1016/S0738-081X(99)00050-4
Global control and Leishmania HIV co-infection.
P. Desjeux (1999)
10.1097/01.aids.0000210614.45212.0a
Association between genital schistosomiasis and HIV in rural Zimbabwean women
E. Kjetland (2006)
10.1097/00002030-199312000-00005
The mortality and pathology of HIV infection in a West African city
S. Lucas (1993)
Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome.
(1985)
10.1093/CLINIDS/23.5.1168
Infection with human immunodeficiency virus does not influence the clinical severity of scrub typhus.
P. Kantipong (1996)
10.1037/e547332006-001
The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
S. Hewitt (1996)
10.1093/INFDIS/168.5.1087
Differential mortality by measles vaccine titer and sex.
E. A. Holt (1993)
10.4269/AJTMH.2007.77.627
Malaria treatment efficacy among people living with HIV: the role of host and parasite factors.
Miriam K Laufer (2007)
10.1093/CLINIDS/17.1.140
St. Louis encephalitis in patients with human immunodeficiency virus infection.
P. Okhuysen (1993)
A prospective evaluation of Mycobacterium avium complex colonization of the respiratory and gastrointestinal tracts of persons with HIV infection
JA JrHavlik (1993)
Trypanosoma cruzi menignoencephalitis in HIV-infected patients
N Silva (1999)
10.1590/S0042-96862004000500009
Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
F. Mwaungulu (2004)
10.1097/00002030-199405000-00010
Effects of high‐dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double‐blind, placebo‐controlled study
M. Youle (1994)
Mycobacterium marinum infection in a patient with cryptosporidiosis and AIDS
MW Lambertus (1988)
10.1007/BF01709591
Pleural and peritoneal leishmaniasis in an AIDS patient
F. Muñoz-Rodríguez (2005)
10.1086/508892
HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
Snehal N. Shah (2006)
10.1378/CHEST.98.5.1051
Tuberculosis in the time of AIDS. The facts and the message.
J. Ellner (1990)
Mycobacterium xenopi : Innocent bystander or emerging pathogen? Author's reply
Tajuddin M. Jiva (1997)
10.1016/0140-6736(90)92096-Z
Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
C. Gilks (1990)
Prevalence of Toxoplasma antibodies in Chiang Mai population.
N. Morakote (1984)
10.1016/S0163-4453(85)90870-9
Coxiella burnetii infection in immunocompromised patients.
S. Heard (1985)
10.1128/JCM.24.6.959-962.1986
Detection of enteropathogens in fatal and potentially fatal diarrhea in Cairo, Egypt.
S. Shukry (1986)
10.1016/0163-4453(90)91701-E
Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire.
R. Colebunders (1990)
10.1086/520136
Implications of the human immunodeficiency virus epidemic for control and eradication of measles.
W. Moss (1999)
10.1046/J.1365-2125.1999.00005.X
Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
J. Coller (1999)
10.1056/NEJM200001063420113
West Nile viral encephalitis in an HIV-positive woman in New York.
I. Szilak (2000)
10.4269/AJTMH.2002.66.56
HIV infection, malaria, and pregnancy: a prospective cohort study in Kigali, Rwanda.
J. Ladner (2002)
Saude do Brasil: Dados e pesquisa em DST e AIDS
Ministerio da (2002)
10.1056/NEJM199309303291403
Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
B. Luft (1993)
10.1007/S11908-007-0022-3
The interaction between HIV and malaria in Africa
Miriam K Laufer (2007)
10.1016/S0264-410X(00)00079-7
Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.
F. Kroon (2000)
10.1590/S0036-46652001000200004
Pancreatic involvement in co-infection visceral leishmaniasis and HIV: histological and ultrastructural aspects.
E. Chehter (2001)
10.1097/00006454-199312000-00013
Penicillium marneffei infection in children infected with human immunodeficiency virus
V. Sirisanthana (1993)
10.1128/JVI.78.5.2454-2459.2004
Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens
E. Aandahl (2004)
10.1056/NEJM199707313370504
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group.
R. Rolfs (1997)
10.1128/JCM.34.3.731-733.1996
Mycobacterium malmoense bacteremia in two AIDS patients.
M. Fakih (1996)
Antibody to HIV and suboptimal response to hepatitis B vaccination
A C Collier (1988)
10.1007/BF00202052
Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon
P. Ndumbe (2004)
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific bacterial effect of BCG? Vaccine
ML Garly (2003)
10.1016/S1473-3099(04)01060-6
Global strategies to prevent bacterial pneumonia in adults with HIV disease.
D. Feikin (2004)
Interactions between human immunodeficiency virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus
C Housset (1992)
Norvir package insert
(2004)
Musher DM: Syphilis, neurosyphilis, penicillin, and AIDS
(1991)
10.1007/BF00919599
Acute necrotizing measles encephalitis in a child with AIDS
C. Lacroix (2004)
10.1038/35095579
The germless theory of allergic disease: revisiting the hygiene hypothesis
M. Wills-Karp (2001)
Cutaneous Acanthamoeba infection in the acquired immunodeficiency syndrome: response to multidrug therapy.
S. Hunt (1995)
10.1590/S0074-02761992000400005
Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
E. Machado (1992)
Disseminated infection with Simiae-Avium group mycobacteria in persons with AIDS--Thailand and Malawi, 1997.
L. Reller (2002)
10.1038/27570
Maternal antibodies block malaria
M. Fried (1998)
10.1086/340104
Prevention of yellow fever in persons traveling to the tropics.
T. Monath (2002)
10.1093/INFDIS/164.5.994
Natural history of disseminated Mycobacterium avium complex infection in AIDS.
M. Jacobson (1991)
10.1086/318478
Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus.
L. Fonquernie (2001)
10.1164/AJRCCM.151.1.7812542
Accelerated course of human immunodeficiency virus infection after tuberculosis.
C. Whalen (1995)
10.1111/j.1365-4362.1992.tb01390.x
Buruli Ulcer and HIV infection
S. Allen (1992)
10.1136/jcp.44.4.346
Strongyloides stercoralis hyperinfection in an HIV positive patient.
J. Harcourt-Webster (1991)
Die HIV-assoziierte Penicilliummarneffei-infektion
CM Kronauer (1993)
10.1046/j.1365-2249.1997.00293.x
CD4+ T cell‐mediated fatal hyperinflammatory reactions in mice infected with Penicillium marneffei
N. Kudeken (1997)
Possible reactivation of hepatitis D with chronic antigenaemia by HIV
A G Shattock (1987)
10.1046/J.1365-2125.1998.00765.X
Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.
A. Adedoyin (1998)
A randomized trial of enhanced therapy for early syphilis in patients with and without HIV infection
RT Rolfs (1997)
10.1056/NEJM199907153410303
Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis.
R. Buller (1999)
10.1097/00002030-200309050-00006
Persistent immune activation in HIV-1 infection is associated with progression to AIDS
M. Hazenberg (2003)
10.1001/ARCHPEDI.1988.02150120025021
Measles in hospitalized African children with human immunodeficiency virus.
M. Sension (1988)
10.1086/422724
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
F. Gordin (2004)
10.1001/ARCHDERM.1994.01690010125029
Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease.
K. Smith (1994)
An analysis of T cell responsiveness in Indian kala-azar.
D. Sacks (1987)
10.1007/BF02111493
Mycobacterium haemophilum: An emerging pathogen
T. Kiehn (2005)
10.1007/BF01967089
Yaws, an endemic treponematosis reconsidered in the HIV era
G. T. Noordhoek (2005)
Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and HIV co-infections
DMS Karanja (1997)
10.3201/EID1010.030985
Current Epidemiology of Pneumocystis Pneumonia
A. Morris (2004)
Blastomycosis in the immunocompromised patient.
P. Pappas (1997)
A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.
R. Perry (1998)
10.1001/JAMA.1988.03720040037023
The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire.
A. Greenberg (1988)
10.1086/324087
Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts.
T. Tantawichien (2001)
10.1016/0169-4758(94)90270-4
Leishmaniasis and AIDS co-infection: the Spanish example.
J. Alvar (1994)
10.1097/00002030-199301000-00012
Q fever and HIV infection.
D. Raoult (1993)
10.1093/INFDIS/157.2.314
Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection.
R. Colebunders (1988)
10.1086/318146
Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases.
G. Benard (2000)
10.1056/NEJM198904203201604
Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome.
J. Pape (1989)
10.1016/0035-9203(88)90469-5
Brucellosis in hairy cell leukaemia.
E. Oksenhendler (1988)
Immunity in Q fever.
J. Kazár (1988)
[Acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire: clinical and epidemiological observations].
W. Odio (1985)
10.1086/498577
Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study.
M. Kamya (2006)
10.1093/tropej/39.4.219
HIV, BCG and TB in children: a case control study in Lusaka, Zambia.
G. Bhat (1993)
10.4269/AJTMH.2007.77.823
High proportion of isosporiasis among HIV-infected patients with diarrhea in southern India.
R. Vignesh (2007)
HIV-infected children should be immunized against measles.
(1989)
Acanthamoeba meningoencephalitis: Diagnosis by squash preparation of brain biopsy specimen
E K Miyamato (1985)
10.1056/NEJM199503233321206
Prophylaxis against Pneumocystis carinii Pneumonia among Children with Perinatally Acquired Human Immunodeficiency Virus Infection in the United States
R. Simonds (1995)
10.1056/NEJM196711302772204
Isolation of hartmannella species from human throats.
S. Wang (1967)
10.1128/JCM.33.1.137-140.1995
Isolation of the newly described species Mycobacterium celatum from AIDS patients.
E. Tortoli (1995)
10.1086/523731
Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.
J. Vyas (2007)
Plasmodium falciparum antigeninduced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-α
L Xiao (1998)
10.1590/S0037-86821994000100008
Leptospirosis patient with AIDS: the first case reported.
E. S. Neves (1994)
10.1093/CLINIDS/17.3.508
Mycobacterium simiae infection in Israeli patients with AIDS.
D. Huminer (1993)
10.4049/jimmunol.179.12.8372
Mechanisms of Vaccine-Induced Protective Immunity against Coxiella burnetii Infection in BALB/c Mice1
Guoquan Zhang (2007)
10.1093/INFDIS/171.3.531
T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects.
M. Roos (1995)
10.1093/CLINIDS/20.6.1565-A
Mycobacterium genavense infection in a patient with AIDS who was successfully treated with clarithromycin.
P. Matsiota-Bernard (1995)
RE: Effect of HIV infection on the course of syphilis and on the response to treatment
DM Musher (1990)
10.1086/315345
Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania.
G. Poggensee (2000)
10.1016/0090-1229(89)90173-6
Concurrent infections with Strongyloides and T-cell leukemia virus and their possible effect on immune responses of host.
Y. Sato (1989)
10.1128/CMR.8.1.146
Endemic mycoses in AIDS: a clinical review.
J. Wheat (1995)
10.1111/j.1348-0421.1991.tb01545.x
Lymphocyte Subpopulations and Cytokine Production in Paracoccidioidomycosis Patients
A. J. Bava (1991)
10.1136/adc.63.10.1268
Disseminated BCG in HIV infection.
J. Ninane (1988)
10.1177/095646249400500517
Female Genital Schistosomiasis as a Risk-Factor for the Transmission of HIV
H. Feldmeier (1994)
Ineffectiveness of trimethoprimsulfamethoxazole prophylaxis and the importance of bacterial and viral co-infections in African children with Pneumocystis carinii pneumonia
SA Mahdi (2002)
10.1097/00002030-200012220-00020
Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.
J. Berenguer (2000)
Response of HIVinfected adults to measles-rubella vaccination
M A Sprauer (1993)
10.1097/00002030-199401000-00013
HIV‐1 incidence and HIV‐1 ‐associated mortality in a rural Ugandan population cohort
D. Mulder (1994)
10.1086/517006
Cutaneous infection caused by Mycobacterium gordonae in a human immunodeficiency virus-infected patient receiving antimycobacterial treatment.
S. Rusconi (1997)
10.1056/NEJM198309083091002
The polymicrobial origin of intestinal infections in homosexual men.
T. Quinn (1983)
10.1093/INFDIS/173.6.1490
Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir?
S. Chariyalertsak (1996)
10.1016/S0140-6736(97)07529-6
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
A. Carr (1998)
10.1128/JCM.41.4.1458-1462.2003
Molecular Analysis of the 18S rRNA Gene of Cryptosporidium Parasites from Patients with or without Human Immunodeficiency Virus Infections Living in Kenya, Malawi, Brazil, the United Kingdom, and Vietnam
W. Gatei (2003)
10.1073/PNAS.90.3.948
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
J. K. Actor (1993)
10.4049/jimmunol.178.11.6958
Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS1
K. Brown (2007)
[Mycobacterium avium complex].
H. Leclerc (1995)
10.1097/QAD.0B013E3282A4A64D
HIV-associated cryptococcal meningitis.
J. Jarvis (2007)
10.4269/AJTMH.1997.56.603
Granulomatous amebic encephalitis due to Balamuthia mandrillaris (Leptomyxiidae): report of four cases from Mexico.
J. M. Riestra-Castaneda (1997)
Case–control study of risk factors for Penicillium marneffei infection in HIV-infected patients in northern Thailand
S Chariyalertsak (1997)
HIV infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
B Soto (1997)
10.1016/0001-706X(95)00073-N
A study of Toxoplasma and Cytomegalovirus serology in tuberculosis and in HIV-infected patients in Burkina Faso.
E. Ledru (1995)
Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire
AE Greenberg (1991)
10.1002/1097-0142(19901201)66:11<2417::AID-CNCR2820661129>3.0.CO;2-G
Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma
J. Dutcher (1990)
10.1016/0035-9203(94)90531-2
Eosinophils: a putative marker of immunodepression in HIV-infected African patients with tuberculosis?
E. Ledru (1994)
10.1126/science.273.5272.228
Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus
C. Karp (1996)
10.1093/CLINIDS/11.SUPPLEMENT_7.S1629
Tropical disease in the immunocompromised host: melioidosis and pythiosis.
D. Tanphaichitra (1989)
10.1086/500245
Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi.
Miriam K Laufer (2006)
10.1007/978-1-4615-3306-1_4
The Ecology of Blastomyces dermatitidis
A. Disalvo (1992)
10.1128/JCM.39.12.4535-4540.2001
Differences in Clinical and Laboratory Diagnostic Characteristics of Penicilliosis Marneffei in Human Immunodeficiency Virus (HIV)- and Non-HIV-Infected Patients
S. Wong (2001)
10.1016/S0002-9343(97)00048-X
Clinical significance of eosinophilia in HIV-infected individuals.
D. Skiest (1997)
10.1097/00126334-200010010-00006
Eradication of Cryptosporidia and Microsporidia Following Successful Antiretroviral Therapy
Y. Miao (2000)
10.1086/429668
Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.
M. Brown (2005)
10.1086/425359
Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection.
H. Sindermann (2004)
10.1086/319686
Malaria infection induces virus expression in human immunodeficiency virus transgenic mice by CD4 T cell-dependent immune activation.
C. Freitag (2001)
10.7326/0003-4819-117-10-837
Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival.
B. Scharschmidt (1992)
10.1086/424666
Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
M. Wallace (2004)
10.1097/00042560-199808010-00010
Detection of picobirnavirus in HIV-infected patients with diarrhea in Argentina.
M. Giordano (1998)
10.1086/318533
Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction.
S. Permar (2001)
10.1093/LABMED/25.6.386
Cutaneous Acanthamoeba Infection Associated With Acquired Immunodeficiency Syndrome
C. Park (1994)
Mycobacterium gordonae: A possible opportunistic respiratory tract pathogen in patients with advanced HIV, type 1 infection
TW Barber (1991)
10.1056/NEJM198909213211205
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
S. Chuck (1989)
10.1038/nrmicro1550
Global measles elimination
W. Moss (2006)
10.1086/517147
Declining prevalence of cryptosporidiosis in San Francisco.
L. S. Kim (1998)
10.1016/0002-9343(90)90162-7
Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy.
L. A. Ross (1990)
Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature.
K. O'Brien (1995)
10.1086/378806
Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?
L. Kerbiriou (2003)
10.1097/00002030-199205000-00005
The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico
A. Mohar (1992)
10.1097/00005792-200101000-00006
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients: A Comparative Study
V. Pintado (2001)
10.7326/0003-4819-107-6-944_1
Babesiosis and infection with human immunodeficiency virus (HIV)
D. Benezra (1987)
10.1016/S0140-6736(00)03232-3
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Gilbert GREUB (2000)
Measles giant cell pneumonia in a child with HIV infection
S Nadel (1991)
Syphilis and neurosyphilis in a HIV type-1 seropositive population: Evidence for frequent serologic relapse after therapy
JL Malone (1995)
10.1001/ARCHINTE.1996.00440030127015
Serologic response to treatment of syphilis in patients with HIV infection.
A. Yinnon (1996)
10.1037/e548312006-001
Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Acip (2004)
10.1086/342510
Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients.
A. Sartori (2002)
10.1097/00002030-199804000-00006
Does hepatitis C virus co‐infection accelerate clinical and immunological evolution of HIV‐infected patients?
L. Piroth (1998)
10.1097/00063198-200305000-00010
HIV and respiratory infections in children
S. Graham (2003)
10.1097/00042560-199502000-00011
Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya.
C. Gilks (1995)
Provisional WHO/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa
WhoUnaids (2004)
10.4269/AJTMH.2007.77.350
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
K. Supparatpinyo (2007)
10.1097/00000478-199804000-00015
Taenia crassiceps invasive cysticercosis: a new human pathogen in acquired immunodeficiency syndrome?
A. François (1998)
10.1086/313843
Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.
J. Kaplan (2000)
10.1016/S0169-4758(00)01699-9
Cryptosporidium systematics and implications for public health.
L. Xiao (2000)
10.1086/498023
Increased prevalence of severe malaria in HIV-infected adults in South Africa.
C. Cohen (2005)
10.3109/00365548809032451
Herpes zoster in African patients: an early manifestation of HIV infection.
P. Van de Perre (1988)
Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin.
P. Fischer (1995)
10.7326/0003-4819-116-10-840
Cryptosporidium infection and CD4 counts.
T. Flanigan (1992)
Detection and characterization of human astroviruses in children with acute gastroenteritis in Blatyre, Malawi
N A Cunliffe (2002)
10.1086/513666
Mycobacterium kansasii disease in patients infected with human immunodeficiency virus.
R. Campo (1997)
10.1016/0006-2952(92)90453-P
Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs.
K. N. Bangchang (1992)
10.1590/S0042-96862004000400011
Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
C. Gill (2004)
10.1046/j.1351-5101.2003.00696.x
Unusual form of neurocysticercosis associated with HIV infection
P. Delobel (2004)
Good tolerance and efficacy of yellow fever vaccination among carriers of human immunodeficiency virus
C Goujon (1995)
10.1128/JCM.33.9.2514-2515.1995
Species-specific Mycobacterium genavense DNA in intestinal tissues of individuals not infected with human immunodeficiency virus.
J. Dumonceau (1995)
Scabies in AIDS.
M. Orkin (1993)
10.7326/0003-4819-138-3-200302040-00012
Hepatitis C in the HIV-Infected Person
M. Sulkowski (2003)
Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas’ disease co-infections in Brazil
L Perez-Ramirez (1999)
Immunity to pathogenic free-living amoebae: role of cell-mediated immunity.
R. Cursons (1980)
10.1097/00006454-199503000-00019
DIFFUSELY DISSEMINATED CUTANEOUS LEISHMANIA MAJOR INFECTION IN A CHILD WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
D. Gillis (1995)
10.1590/S0036-46651993000600001
Regional variation in toxoplasmosis seronegativity in the São Paulo metropolitan region.
A. Guimarães (1993)
10.4269/AJTMH.2007.77.507
Effect of diethylcarbamazine on HIV load, CD4%, and CD4/CD8 ratio in HIV-infected adult Tanzanians with or without lymphatic filariasis: randomized double-blind and placebo-controlled cross-over trial.
N. Nielsen (2007)
10.3109/00365549509032728
Coxiella burnetii infection in subjects with HIV infection and HIV infection in patients with Q fever.
M. Montes (1995)
patients responding to highly active anti - retroviral therapy
E Brummer (2002)
10.1016/S1074-7613(01)00090-5
Mechanism of measles virus-induced suppression of inflammatory immune responses.
J. Marie (2001)
10.1093/CLINIDS/14.4.871
Penicillium marneffei infection in patients infected with human immunodeficiency virus.
N. Vanittanakom (1997)
The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with HIV infection
SM Gordon (1994)
10.1016/J.TUBE.2003.10.001
Disseminated Mycobacterium haemophilum infection as initial manifestation of AIDS.
E. Stürenburg (2004)
10.1136/bmj.309.6949.272a
Pneumocystis pneumonia
R. Evans (1994)
10.1007/BF01719280
Histoplasmosis capsulati and duboisii in Europe: The impact of the HIV pandemic, travel and immigration
R. Manfredi (2005)
10.4269/AJTMH.2004.71.679
Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort.
G. A. S. Pereira (2004)
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation.
D. Goletti (1996)
10.1128/JCM.28.7.1642-1644.1990
Natural habitat of Cryptococcus neoformans var. gattii.
D. Ellis (1990)
10.1086/374600
Decrease in human immunodeficiency virus type 1 load during acute dengue fever.
G. Watt (2003)
Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to HIV infection and liver disease
M E Eyster (1994)
10.1086/319989
Influenza and human immunodeficiency virus infection: absence of HIV progression after acute influenza infection.
M. Golden (2001)
Invasive meningococcal disease and HIV coinfection.
D. Couldwell (2001)
10.1097/00002030-199906180-00009
Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
F. Laguna (1999)
Measles, Mumps, and Rubella - Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Vol. 47/No. RR-8.
J. Watson (1998)
10.1128/JCM.33.8.2136-2138.1995
Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei.
L. Kaufman (1995)
[African histoplasmosis due to Histoplasma capsulatum var. duboisii: relationship with AIDS in recent Congolese cases].
J. Chandenier (1995)
Mycobacterium kansasii infections in patients positive for HIV
JL Carpenter (1991)
10.1037/e548512006-001
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
C. Bridges (2001)
10.1016/0035-9203(90)90292-M
Is African histoplasmosis an opportunistic fungal infection in AIDS?
B. Carme (1990)
10.1016/S0037-1963(00)90064-7
Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy.
R. Moore (2000)
A randomized trial of clarithryomycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome
M Pierce (1996)
10.1038/sj.bjc.6600745
Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
M. Dedicoat (2003)
10.1097/00001432-200402000-00011
Transmission and disease association of Kaposi's sarcoma-associated herpesvirus: recent developments
C. Henke-Gendo (2004)
Alteration in the natural history of neurosyphilis by concurrent infection with HIV
DR Johns (1987)
10.4269/AJTMH.1988.38.315
Toxoplasmosis in Panama: a 10-year study.
O. Sousa (1988)
10.1016/S0140-6736(01)05706-3
Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children
N. Cunliffe (2001)
10.1046/J.1469-0691.2003.00505.X
Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature.
J. Losa (2003)
10.1016/0035-9203(85)90112-9
Correlation between cell-mediated immunity and clinical forms of paracoccidioidomycosis.
N. G. Mota (1985)
10.1586/14787210.5.2.231
Interactions and management issues in HSV and HIV coinfection
M. Ramaswamy (2007)
10.1093/INFDIS/169.2.289
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection.
D. Chin (1994)
Sexual behavior and sexually transmitted infections in men living in rural Madagascar
PDC Leutscher (2003)
10.1016/J.PT.2005.04.010
Modulation of immune responses during HIV-malaria co-infection in pregnancy.
R. Ned (2005)
Immunity to pathogenic freeliving amoebae: Role of cell-mediated immunity
RTM Cursons (1980)
Taenia-crassiceps-Infektion bei AIDS
H Klinker (1992)
10.1097/00002030-199507000-00009
Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection
P. Bloland (1995)
10.1086/344325
Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.
P. del Giudice (2002)
10.1016/S0169-4758(99)01431-3
Leishmania-HIV interaction: immunopathogenic mechanisms.
D. Wolday (1999)
10.1086/517380
Lymph node human immunodeficiency virus RNA levels and resistance mutations in patients receiving high-dose saquinavir.
J. Schapiro (1998)
10.1056/NEJM200011163432004
Atovaquone and azithromycin for the treatment of babesiosis.
P. Krause (2000)
10.1128/JCM.34.10.2503-2505.1996
Diagnostic antigenemia tests for penicilliosis marneffei.
L. Kaufman (1996)
10.1097/QCO.0b013e3282e9ac03
Below the belt: new insights into potential complications of HIV-1/schistosome coinfections
W. Secor (2007)
10.1086/513642
Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.
E. Talbot (1997)
Babesiosis, asplenia, and AIDS (letter)
KR Ong (1990)
10.1086/379737
Placental malaria and perinatal transmission of human immunodeficiency virus type 1.
I. Inion (2003)
10.4269/AJTMH.2004.70.298
Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
J. Mira (2004)
10.1093/CLINIDS/22.6.1132-A
Paracoccidioidomycosis and AIDS.
S. A. Nishioka (1996)
10.1086/516941
Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis.
H. Albrecht (1997)
10.1093/CLINIDS/16.1.107
Disseminated atypical blastomycosis in two patients with AIDS.
G. Tan (1993)
10.7326/0003-4819-137-5_PART_2-200209031-00002
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002
H. Masur (2002)
10.7326/0003-4819-116-10-847
Blastomycosis in patients with the acquired immunodeficiency syndrome.
P. Pappas (1992)
Disseminated Penicillium marneffei infection as an imported disease in HIV-1 infected patients. Description of two cases and a review of the literature.
I. Kok (1994)
10.1097/00002030-200203080-00022
Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy.
C. Hung (2002)
10.1001/JAMA.293.12.1461
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria.
H. Reyburn (2005)
LEM: The Mycobacterium avium complex
CB Inderlied (1993)
10.1086/514212
Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha.
L. Xiao (1998)
10.1093/CLIND/24.4.661
A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival.
P. L. Alpert (1997)
10.1378/CHEST.104.1.119
Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature.
K. D. Lessnau (1993)
Continuous high-grade Mycobacterium avium–intracellulare bacteremia in patients with AIDS
B Wong (1985)
10.1046/J.1365-2125.2001.01393.X
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers.
Y. Khaliq (2001)
10.1097/00002030-200404300-00014
The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women
V. Mwapasa (2004)
10.1016/S0140-6736(02)11913-1
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
C. Thio (2002)
Human Toxoplasma infection in Kuna and Embera children in the Bayano and San Blas, eastern Panama.
G. Etheredge (1995)
10.1086/323981
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus.
C. Paddock (2001)
Respiratory syncytial virus infection in an adult with AIDS (letter)
S Sriskandan (1993)
10.4269/AJTMH.1998.59.813
Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.
M. Parise (1998)
10.1046/j.1365-2133.1997.18651934.x
Atypical Lyme borreliosis in an HIV‐infected man
F. Cordoliani (1997)
10.1093/CLINIDS/21.4.852
Cholecystectomy in patients with AIDS: clinicopathologic correlations in 107 cases.
A. French (1995)
Respiratory syncytial virus infection in HIV-infected children
S Chandwani (1990)
AIDS--the Baragwanath experience. Part III. HIV infection in adults at Baragwanath Hospital.
A. Karstaedt (1992)
Louis encephalitis in patients with human immunodeficiency virus infection
P C Okhuysen (1993)
10.1097/00007611-199403000-00011
Crusted (Norwegian) Scabies in Patients With AIDS: The Range of Clinical Presentations
I. Schlesinger (1994)
10.7326/0003-4819-78-2-271
Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective.
R. Giannella (1973)
10.1016/0035-9203(95)90508-1
Serological responses to brucellosis in HIV-seropositive patients.
J. Paul (1995)
10.1001/JAMA.1994.03520030054028
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?
J. S. Bakken (1994)
10.1016/0926-9959(95)96267-C
Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS.
E. Dauden (1996)
10.1097/00007611-199010000-00024
Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage.
M. Kramer (1990)
10.1136/bmj.294.6588.1656
Possible reactivation of hepatitis D with chronic delta antigenaemia by human immunodeficiency virus.
A. Shattock (1987)
Enteropathic AIDS in Uganda. An endoscopic, histological and microbiological study.
N. Sewankambo (1987)
10.1086/516130
Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature.
M. D. Ferreira (1997)
10.1086/520190
STATE‐OF‐THE‐ART CLINICAL ARTICLE
C. Kauffman (1999)
10.1093/CLINIDS/24.5.1012
Brucella melitensis osteitis following craniotomy in a patient with AIDS.
C. Galle (1997)
10.1093/OXFORDJOURNALS.AJE.A009015
Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival.
J. Colford (1996)
10.1086/339940
Assessing eosinophil count as a marker of immune activation among human immunodeficiency virus-infected persons in sub-Saharan Africa.
T. Chorba (2002)
Anonymous: Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome
(1985)
10.1086/497269
Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
P. Phillips (2005)
Atypical scabies in HIVpositive patients
JJ Portu (1996)
Mycobacterium avium– M. intracellulare isolates from patients with or without AIDS
CR JrHorsburgh (1986)
10.1086/343049
Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
S. Madhi (2002)
10.1590/S0074-02761993000300022
Reactivation of Chagas' disease successfully treated with benznidazole in a patient with acquired immunodeficiency syndrome.
S. Nishioka (1993)
10.1097/00006454-199709000-00011
Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children.
I. Kalyesubula (1997)
10.1056/NEJM199212033272306
Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.
S. B. Porter (1992)
Progressive immunodeficiency due to infection with HIV does not lead to waning immunity to measles in a cohort of homosexual men
A R Zolopa (1994)
10.1084/JEM.175.2.331
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals
H. Groux (1992)
10.1016/0035-9203(95)90425-5
Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire.
H. A. Méda (1995)
10.1016/S0923-2494(97)82875-1
Immunology of HIV infection.
G. Pantaleo (1997)
10.1111/j.0141-9838.2004.00701.x
Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re‐activates replication of endogenous HIV in cells from HIV‐infected adults
K. Froebel (2004)
10.1093/CLINIDS/23.6.1327
Fatal Mycobacterium fortuitum meningitis in a patient with AIDS.
M. Smith (1996)
10.1056/NEJM199608083350603
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
M. Pierce (1996)
10.1001/ARCHINTE.1995.00430040074009
Clinical and Epidemiologic Features of Infection With Mycobacterium genavense
M. Péchère (1995)
10.1016/S0091-6749(95)70100-1
Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS.
R. Paganelli (1995)
10.1086/379020
Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases.
Thomas R Deetz (2003)
10.1086/511882
Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
P. German (2007)
10.1084/JEM.175.3.789
Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients
J. Chehimi (1992)
10.1097/01.aids.0000247572.95880.92
Interactions between HIV and malaria in non-pregnant adults: evidence and implications
Kirsten Hewitt (2006)
10.1016/S0002-9343(89)80631-X
Strongyloides stercoralis hyperinfection in the acquired immunodeficiency syndrome.
V. Neto (1989)
10.1086/597677
Primary amebic meningoencephalitis in a patient with AIDS: unusual protozoological findings.
J. D. de Jonckheere (1997)
10.1126/SCIENCE.1352913
Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.
P. Cameron (1992)
10.7326/0003-4819-113-11-872
Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment.
D. Musher (1990)
10.1097/00002030-200302140-00018
Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia
G. Aderaye (2003)
10.1093/CLINIDS/21.5.1275
Paracoccidioidomycosis and AIDS: an overview.
L. Goldani (1995)
10.1097/00002030-200005260-00006
`Modeling' relationships among HIV-1 replication, immune activation and CD4+ T-cell losses using adjusted correlative analyses
M. Lederman (2000)
10.7326/0003-4819-109-6-502
Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS).
G. Lake-Bakaar (1988)
10.1097/00126334-200404150-00001
The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics
L. Corey (2004)
10.4269/AJTMH.1990.42.83
HIV-related enteropathy in Zambia: a clinical, microbiological, and histological study.
C. Conlon (1990)
encephalitis: A review of 11 cases in a 1995 Dallas, Texas epidemic
M Wasay (2000)
10.1136/STI.72.2.115
Crusted ("Norwegian") scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission.
E. Corbett (1996)
10.1097/00002030-199308000-00025
Coxiella burnetii infection among HIV-1-infected people living in Paris, France.
L. Bélec (1993)
10.1111/j.1550-7408.2003.tb00620.x
Cryptosporidium Species and Genotypes in HIV‐Positive Patients in Lima, Peru
V. Cama (2003)
10.7326/0003-4819-109-6-474
Isospora belli infection: treatment with pyrimethamine.
L. Weiss (1988)
10.1097/00002030-199209000-00020
Brucellosis and HIV infection: a casual association?
J. Pedro-Botet (1992)
10.1097/00126334-200311010-00005
Effect of Maternal HIV and Malaria Infection on Pregnancy and Perinatal Outcome in Zimbabwe
C. Ticconi (2003)
10.1093/INFDIS/165.6.1082
Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.
S. D. Nightingale (1992)
10.1086/520280
Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients.
T. Sirisanthana (1998)
10.4269/AJTMH.1996.55.1.TM0550010001
Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
J. Kaplan (1996)
10.1007/BF01709454
Brucellosis in patients infected with the human immunodeficiency virus
S. Moreno (2005)
10.3201/eid0909.020560
Ehrlichia chaffeensis Infections among HIV-infected Patients in Human Monocytic Ehrlichiosis–Endemic Area
T. R. Talbot (2003)
10.1016/S0140-6736(05)65044-1
Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children
H. Oshitani (1996)
Neurosyphilis. A comparative study of the effects of infection with HIV
DA Katz (1993)
10.1093/CLINIDS/23.1.125
Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases.
T. Duong (1996)
10.4269/AJTMH.1999.61.198
Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil.
L. Perez-Ramirez (1999)
10.1002/JCA.2920080205
Treatment of babesiosis by red blood cell exchange in an HIV‐positive, splenectomized patient
L. Machtinger (1993)
10.1097/00002030-200311210-00020
The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda
H. Brahmbhatt (2003)
in Uganda . An endoscopic , histological and microbiological study
R Colebunders (1987)
10.1128/CMR.6.2.89
Paracoccidioidomycosis: an update.
E. Brummer (1993)
10.1097/00006454-199012000-00022
A randomized, controlled trial of vitamin A in children with severe measles.
G. Hussey (1990)
10.1001/JAMA.1989.03420170056030
Measles and measles immunity in children infected with human immunodeficiency virus.
K. Krasinski (1989)
10.1086/392514
Clinical and therapeutic management of pulmonary Mycobacterium xenopi infection in HIV-positive patients.
L. Gazzola (2004)
10.1016/0167-5699(95)80119-7
Immune activation is a dominant factor in the pathogenesis of African AIDS.
Z. Bentwich (1995)
10.1001/ARCHDERM.1995.01690230069011
Disseminated acanthamebiasis in patients with AIDS. A report of five cases and a review of the literature.
G. Murakawa (1995)
10.1016/0169-4758(92)90104-A
HIV and malaria: a lesson in immunology?
G. Butcher (1992)
10.1093/CLINIDS/21.5.1092
Cyclospora cayetanensis infection in patients with and without AIDS: biliary disease as another clinical manifestation.
J. Sifuentes-Osornio (1995)
10.1001/JAMA.1984.03340430018008
Whose Schizophrenia Is It, Anyway?
L. Alverno (1984)
10.4269/AJTMH.2002.67.521
Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease.
A. Sartori (2002)
10.4049/jimmunol.166.6.4244
Opposite Effects of IL-10 on the Ability of Dendritic Cells and Macrophages to Replicate Primary CXCR4-Dependent HIV-1 Strains1
P. Ancuta (2001)
10.1097/INF.0b013e3180621192
Seasonality, Incidence, and Repeat Human Metapneumovirus Lower Respiratory Tract Infections in an Area With a High Prevalence of Human Immunodeficiency Virus Type-1 Infection
S. Madhi (2007)
10.1097/00002030-200303070-00014
The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya
J. Ayisi (2003)
10.1128/CMR.17.1.208-217.2004
Strongyloides stercoralis in the Immunocompromised Population
P. Keiser (2004)
10.1016/S0022-3476(09)90015-4
Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate.
P. Aaby (1993)
Clinical use of ribavirin in measles: A summarized review
G Banks (1984)
10.1093/CLINIDS/23.1.138
Infectious complications of human T cell leukemia/lymphoma virus type I infection.
B. Marsh (1996)
Acanthamoeba infection presenting as skin lesions in patients with the acquired immunodeficiency syndrome.
B. Tan (1993)
10.1093/CLINIDS/20.5.1207
Disseminated acanthamoeba infection in patients with AIDS: case reports and review.
J. P. Sison (1995)
10.1016/0041-3879(85)90037-6
Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
J. Banks (1985)
Chagas’ granulomatous encephalitis in immunosuppressed patients. Computed tomography and magnetic resonance imaging findings
GA diLorenzo (1996)
Lyme disease concurrent with HIV infection
JC Garcia-Monco (1989)
10.1097/00002030-199310000-00023
An easy and quick method for the diagnosis of visceral leishmaniasis in HIV‐1-infected individuals
F. Medrano (1993)
10.1164/ajrccm.164.7.16471
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.
(2001)
10.1016/S0954-6111(08)80039-X
Pneumocystis carinii pneumonia in patients with AIDS in Central Africa.
D. Mcleod (1990)
10.1111/j.1468-1293.2004.00249.x
Epidemiological, clinical and therapeutic features of AIDS‐related Mycobacterium kansasii infection during the HIV pandemic: an 11‐year follow‐up study
R. Manfredi (2004)
10.1097/00002030-199212000-00031
Meningococcal meningitis and HIV infection: results from a case-control study in western Uganda.
W. Kipp (1992)
10.1097/00002030-199102000-00010
Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers.
S. Lallemant-Le Coeur (1991)
A preliminary survey for human immunodeficiency virus (HIV) infections and melioidosis patients in Ubon Tatchathani, Thailand
K Kanai (1992)
10.1093/CLINIDS/18.4.636
Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men.
A. Zolopa (1994)
10.1097/00002030-199602000-00023
Pentamidine isethionate as secondary prophylaxis against visceral leishmaniasis in HIV-positive patients.
J. Pérez-Molina (1996)
10.1136/sti.72.3.176
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG).
H. Schoefer (1996)
10.1111/jon19966294
Chagasic Granulomatous Encephalitis in Immunosuppressed Patients; Computed Tomography and Magnetic Resonance Imaging Findings
Guillermo A. Di Lorenzo (1996)
10.1097/00002030-199911120-00005
Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.
S. Lawn (1999)
10.1016/0035-9203(94)90154-6
Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin.
J. Q. Qu (1994)
10.1016/S0035-9203(03)90040-X
Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults.
A. Elliott (2003)
10.1128/JVI.73.5.4019-4028.1999
Human Herpesvirus 6 Infects Dendritic Cells and Suppresses Human Immunodeficiency Virus Type 1 Replication in Coinfected Cultures
H. Asada (1999)
10.1164/AJRCCM.160.1.9812080
Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.
E. Corbett (1999)
10.1093/CLINIDS/17.5.900
Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS.
J. Torres (1993)
10.1097/00002030-200105040-00010
Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults
N. French (2001)
10.1097/00006454-199309000-00006
Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children.
J. C. King (1993)
Free-living amebas of the genera Acanthamoeba and Naegleria: an overview and basic microbiologic correlates.
E. Bottone (1993)
10.2174/157016208783571937
Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count.
M. Lichtner (2008)
10.1089/088922200309566
Influenza virus upregulates CXCR4 expression in CD4+ cells.
A. Puri (2000)
Nishioka Sde A: Paracoccidioidomycosis and AIDS
(1996)
10.1097/00002030-199611000-00016
Spectrum of disease in Africans with AIDS in London
J. del Amo (1996)
10.1093/INFDIS/173.1.269
Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.
E. Sabin (1996)
[Strongyloides stercoralis hyperinfection in a patient with acquired immunodeficiency syndrome].
G. Sauca Subías (2005)
Increased vertical transmission of HIV from hepatitis C virus-co-infected mothers
R C Hershow (1997)
10.1086/424851
Does tuberculosis increase HIV load?
J. Day (2004)
Medical Management of HIV Infection: 2004 Edition
JG Bartlett (2004)
10.1037/e548372006-001
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.
M. Cetron (2002)
10.1179/136485907X176373
HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania
N. Range (2007)
10.1038/nm1511
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
J. Brenchley (2006)
10.1086/522989
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants.
S. Scott (2007)
10.1093/INFDIS/162.1.208
Absence of bacteremia with Mycobacterium avium-intracellulare in Ugandan patients with AIDS.
D. Okello (1990)
10.1007/BF00202169
Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6
J. Hasler (2004)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar